BAX (Baxter International) Current Accrued Expense: $1,713 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BAX Baxter International Inc BAX
67 GF Score
Price $27.05
GF Value $32.99
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Baxter International Current Accrued Expense?

Baxter International BAX +0.37% 67 Current Accrued Expense is $1,713 Mil as of Jun. 2026. GuruFocus rates BAX with a GF Score™ of 67/100 and a GF Value™ of $32.99 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Baxter International's Current Accrued Expense for the quarter that ended in Jun. 2026 was $1,713 Mil.

Baxter International's quarterly Current Accrued Expense increased from Dec. 2025 ($999 Mil) to Mar. 2026 ($1,765 Mil) but then declined from Mar. 2026 ($1,765 Mil) to Jun. 2026 ($1,713 Mil).

Baxter International's annual Current Accrued Expense declined from Dec. 2023 ($783 Mil) to Dec. 2024 ($748 Mil) but then increased from Dec. 2024 ($748 Mil) to Dec. 2025 ($999 Mil).

Baxter International Current Accrued Expense Related Terms

Baxter International Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Baxter International's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Current Accrued Expense Chart

Baxter International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,034.00 941.00 783.00 748.00 999.00

Baxter International Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,936.00 2,067.00 999.00 1,765.00 1,713.00
BAX
67GF Score
Baxter International Inc BAX
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baxter International Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $1,713 Mil mean?
Baxter International (BAX) has a Current Accrued Expense of $1,713 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Baxter International and its competitors.
Is Baxter International's Current Accrued Expense too high?
Baxter International's current Current Accrued Expense is $1,713 Mil. Overall, Baxter International has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Current Accrued Expense compare to ALGN and SOLV?
Baxter International's Current Accrued Expense of $1,713 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Baxter International and its competitors. Baxter International's current Current Accrued Expense is $1,713 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (BAX) is currently considered Modestly Undervalued. The stock's GF Value™ is $32.99, compared to a current price of $27.05 — trading 18% below its estimated fair value. The current Current Accrued Expense is $1,713 Mil. Baxter International's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Baxter International (BAX), the current Current Accrued Expense is $1,713 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of $27.05 is trading 18% below its estimated GF Value™ of $32.99. GuruFocus considers Baxter International to be Modestly Undervalued.

Key valuation signals for BAX:

  • Current Accrued Expense: $1,713 Mil
  • GF Value™: $32.99 vs. price of $27.05 (18% below fair value)
  • GF Score™: 67/100 with 9 warning signs

No single metric tells the full story. See the BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
67GF Score

Get the complete analysis for BAX

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.05
Price
$32.99
GF Value